Bsopid 8
Bsopid 8
BSOP ID 8 Issued by Standards Unit, Evaluations and Standards Laboratory Centre for Infections
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 1 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
Please note the references are now formatted using Reference Manager software. If you alter or delete text without Reference Manager installed on your computer, the references will not be updated automatically.
Suggested citation for this document: Health Protection Agency (2008). Identification of Clostridium species. National Standard Method BSOP ID 8 Issue 3. http://www.hpa-standardmethods.org.uk/pdf_sops.asp.
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 2 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
INDEX
STATUS OF NATIONAL STANDARD METHODS ................................................................................ 2 INDEX...................................................................................................................................................... 3 AMENDMENT PROCEDURE ................................................................................................................. 4 SCOPE OF DOCUMENT ........................................................................................................................ 5 INTRODUCTION ..................................................................................................................................... 5 TECHNICAL INFORMATION/LIMITATIONS ......................................................................................... 5 1 2 3 SAFETY CONSIDERATIONS ......................................................................................................... 6 TARGET ORGANISMS ................................................................................................................... 6 IDENTIFICATION............................................................................................................................. 7 3.1 3.2 3.3 3.4 3.5 3.6 4 5 MICROSCOPIC APPEARANCE ........................................................................................................ 7 PRIMARY ISOLATION MEDIA .......................................................................................................... 7 COLONIAL APPEARANCE............................................................................................................... 7 TEST PROCEDURES ..................................................................................................................... 8 FURTHER TESTS .......................................................................................................................... 8 STORAGE AND REFERRAL............................................................................................................. 8
IDENTIFICATION OF CLOSTRIDIUM SPECIES - FLOW CHART ............................................... 9 REPORTING .................................................................................................................................. 10 5.1 5.2 5.3 5.3 5.5 5.6 PRESUMPTIVE IDENTIFICATION ................................................................................................... 10 CONFIRMATION OF IDENTIFICATION ............................................................................................. 10 MEDICAL MICROBIOLOGIST ......................................................................................................... 10 CCDC...................................................................................................................................... 10 CENTRE FOR INFECTIONS ........................................................................................................... 10 INFECTION CONTROL STAFF ....................................................................................................... 10
6 7
REFERENCES ...................................................................................................................................... 13
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 3 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
AMENDMENT PROCEDURE
Controlled document reference Controlled document title BSOP ID 8 Identification of Clostridium species
Each National Standard Method has an individual record of amendments. The current amendments are listed on this page. The amendment history is available from [email protected]. On issue of revised or new pages each controlled document should be updated by the copyholder in the laboratory. Amendment Number/ Date 3/ 14.07.08 Issue no. Discarded 2.1 Insert Issue no. 3 Page Section(s) involved Amendment
1 All
NIMAG logo added PDF links amended to read reference document title References reviewed and updated
13
References
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 4 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
INTRODUCTION
Taxonomy
The genus Clostridium currently contains approximately 100 species. In 1994 the heterogeneity of this species was confirmed by 16S rRNA gene sequencing. As a result five new genera and eleven new species were proposed2, none of which appear to be relevant to human infections3.
Principles of Identification
Clues to the identity of certain pathogenic species may be obtained by observing characteristics such as colonial appearance, Gram stain appearances and the presence or absence of -haemolysis. Other phenotypic tests may also be applied to obtain a presumptive identification in conjunction with the use of a good laboratory manual such as the Wadsworth-KTL Anaerobe Laboratory Manual6. It is important to ensure the culture is pure, as the fine spreading growth of some Clostridium species may mask contaminating organisms. If confirmation of identity is required, isolates should be referred to the Anaerobe Reference Laboratory, Cardiff. If Clostridium botulinum is suspected, samples of patients serum, faeces and implicated foodstuff should be referred directly to the Food Safety Microbiology Laboratory, Colindale.
TECHNICAL INFORMATION/LIMITATIONS
N/A
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 5 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
SAFETY CONSIDERATIONS7-18
Hazard Group 2 organisms Refer to current guidance on the safe handling of all Hazard Group 2 organisms documented in this NSM. Laboratory procedures that give rise to infectious aerosols must be conducted in a microbiological safety cabinet. The above guidance should be supplemented with local COSHH and risk assessments. Compliance with postal and transport regulations is essential.
TARGET ORGANISMS
Clostridium species reported to have caused human disease4 Commonly isolated C. perfringens C. septicum C. tertium C. difficile Rarely isolated C. novyii type A C. sordellii Very rarely isolated C. tetani C. histolyticum C. botulinum Commonly isolated non-pathogenic clostridia C. sporogenes C. ramosum C. innocuum C. paraputrificum C. cadaveris C. bifermentans C. fallax C. clostridioforme
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 6 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
3
3.1
IDENTIFICATION
MICROSCOPIC APPEARANCE
(See BSOPTP 39 - Staining Procedures) Gram stain Gram-positive rods, which may possess a single endospore. Some species may be Gramvariable. Spore stain Used to determine the shape and position of the spore (phase contrast microscopy is an alternative option). C. perfringens C. botulinum C. difficile C. novyi C. sordellii C. septicum C. tetani (Does not sporulate on ordinary media) Oval, subterminal Oval, subterminal Oval, subterminal Oval, subterminal Oval, subterminal Round, terminal
3.2 3.3
COLONIAL APPEARANCE
Colonial appearance varies with species and brief descriptions of the most common species are given here Organism Characteristics of growth on agar containing blood after anaerobic incubation at 35C 37C for 40 48 h Large, smooth, regular convex colonies, but may be rough and flat with an irregular edge. Usually has a double zone of -haemolysis; produces lecithinase Large (3 mm), irregularly circular, smooth, greyish, translucent with a fibrillar edge that may spread. Most strains are -haemolytic; produces lipase Glossy, grey, circular colonies with a rough edge; fluoresce greenyellow under UV light. They are usually non-haemolytic, with a characteristic farmyard smell. Raised, circular colonies, which become flattened and irregular in old cultures. Colonies tend to fuse forming a spreading growth with a double zone of -haemolysis. Type A produces lecithinase and lipase Grey-white, convex, circular colonies with crenated edges, which may spread. They may be -haemolytic; produce lecithinase; indole positive Usually produce a thick swarming growth with a narrow zone of -haemolysis Fine swarming growth (may be difficult to see) which may appear -haemolytic
C. perfringens
C. botulinum/ sporogenes
C. difficile
C. novyi
C. tetani
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 7 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
Colonial appearances vary, but may produce a spreading growth which may or may not be -haemolytic
3.4
TEST PROCEDURES
Nagler (see BSOPTP 22 - Nagler test) with C. perfringens antitoxin C. perfringens lecithinase is inhibited by the antitoxin as is that produced by C. bifermentans and C. sordellii. Species other than C. perfringens may produce lecithinase. Also examine for the production of lipase (pearly layer) on egg yolk agar. Reverse CAMP test can be used for differentiation of C. perfringens from other Clostridium species19. Commercial identification kits Results should be interpreted with caution in conjunction with other test results. If clinically indicated refer to the Anaerobe Reference Laboratory for further identification.
3.5 3.6
FURTHER TESTS
N/A
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 8 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
FLOW CHART
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 9 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
5
5.1
REPORTING
PRESUMPTIVE IDENTIFICATION
If appropriate growth characteristics, colonial appearances and Gram stain of the culture are demonstrated and the isolate is metronidazole susceptible.
5.2
CONFIRMATION OF IDENTIFICATION
Following Nagler plate, or Reverse CAMP test for C.perfringens, commercial identification kit results and/or Reference Laboratory report.
5.3
MEDICAL MICROBIOLOGIST
Inform the medical microbiologist of all positive cultures from normally sterile sites. According to local protocols, the medical microbiologist should also be informed of a presumptive and confirmed Clostridium species. when the request card bears relevant information eg: Cases of trauma, penetrating injury, compound fracture or retained foreign body, or known injecting drug abuse (especially heroin) Septic abortion Suspicion of clostridial myonecrosis, (necrotising) myofasciitis, surgical wound infection (especially in cases with occlusive peripheral vascular disease and/or diabetes mellitus) Other serious medical conditions eg alcohol or substance abuse, immunodeficiency, cancer, or persons receiving treatment for cancer (including neutropenia and/or mucositis) Food poisoning (especially involving descending paralysis with cranial nerve involvement) and/or consumption of unusual or imported foods (suspicion of botulism) Investigation of outbreaks Pseudomembranous colitis or antibiotic-related diarrhoea Suspicion of tetanus
CCDC
Refer to local Memorandum of Understanding.
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 10 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
6
6.1
REFERRALS
REFERENCE LABORATORY
For identification and for information on the tests offered, turn around times, transport procedure and the other requirements of the reference laboratory refer to: Anaerobe Reference Laboratory NPHS Microbiology Cardiff University Hospital of Wales Heath Park Cardiff CF14 4XW Telephone +44 (0) 29 2074 2171 or 2378 http://www.hpa.org.uk/cfi/arl/default.htm For toxin detection and for information on the tests offered, turn around times, transport procedure and the other requirements of the reference laboratory refer to: Food Safety Microbiology Laboratory Centre for Infections Health Protection Agency 61 Colindale Avenue London NW9 5HT http://www.hpa.org.uk/cfi/fsml/default.htm Contact CfI main switchboard: Tel. +44 (0) 20 8200 4400
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 11 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 12 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
REFERENCES
1. Department of Health NHS Executive: The Caldicott Committee. Report on the review of patientidentifiable information. London. December 1997. 2. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, et al. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 1994;44:812-26. 3. Koneman EW, Allen S D, Janda W M, Schreckenberger P C, Winn WC J, editors. Color Atlas and Textbok of Diagnostic Microbiology. 5th ed ed. Philadelphia: Lippincott Williams & Wilkins; 1997. p. 709-84 4. Holt JG, Krieg N R, Sneath P H A, Staley J T, Williams S T, editors. Bergey's Manual of Determinative Bacteriology. 9th ed ed. Baltimore: Williams and Wilkins; 1994. p. 560 5. Hatheway CL. Toxigenic clostridia. Clin Microbiol Rev 1990;3:66-98. 6. Jousimies-Somer H, Summanen P, Citron D, et al. Anaerobic Bacteriology Manuel. Anaerobic Bacteriology Manuel. Sixth ed. Star Publishing Company; 2002. p. 54. 7. Advisory Committee on Dangerous Pathogens 2004 Approved List of Biological Agents. http://www.hse.gov.uk/pubns/misc208.pdf. p. 1-17. 8. Health and Safety Executive, editor. Biological Agents: Managing the risks in laboratories and healthcare premises. 5 A.D.
9. Public Health Laboratory Service Standing Advisory Committee on Laboratory Safety. Safety Precautions: Notes for Guidance. 4th ed. London: Public Health Laboratory Service (PHLS); 1993. 10. Control of Substances Hazardous to Health Regulations 2002. General COSHH. Approved Code of Practice and Guidance, L5. Suffolk: HSE Books; 2002. 11. Health and Safety Executive. 5 steps to risk assessment: a step by step guide to a safer and healthier workplace, IND (G) 163 (REVL). Suffolk: HSE Books; 2002. 12. Health and Safety Executive. A guide to risk assessment requirements: common provisions in health and safety law, IND (G) 218 (L). Suffolk: HSE Books; 2002. 13. Health Services Advisory Committee. Safety in Health Service laboratories. Safe working and the prevention of infection in clinical laboratories and similar facilities. 2nd ed. Suffolk: HSE Books; 2003. 14. NHS Estates. Health Building Note 15. Accommodation for pathology services. 1st ed. London: Her Majesty's Stationary Office (HMSO); 1991. (Out of print - 2nd edition in press). 15. BS EN 12469: 2000. Biotechnology - performance criteria for microbiological safety cabinets. London: British Standards Institution (BSI); 2000. 16. BS 5726: 1992. Microbiological safety cabinets. Part 2. Recommendations for information to be exchanged between purchaser, vendor and installer and recommendations for installation. London: British Standards Institution (BSI); 1992. 17. BS 5726: 1992. Microbiological safety cabinets. Part 4. Recommendations for selection, use and maintenance. London: British Standards Institution (BSI); 1992.
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 13 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]
18. Advisory Committee on Dangerous Pathogens. The management, design and operation of microbiological containment laboratories. Suffolk: HSE Books; 2001. 19. Buchanan AG. Clinical laboratory evaluation of a reverse CAMP test for presumptive identification of Clostridium perfringens. J Clin Microbiol 1982;16:761-2. 20. Health Protection Agency. Laboratory Reporting to the Health Protection Agency. Guide for diagnostic laboratories. 2008.
IDENTIFICATION OF CLOSTRIDIUM SPECIES Issue no: 3 Issue date: 14.07.08 Issued by: Standards Unit, Evaluations and Standards Laboratory Page no: 14 of 14 BSOP ID 8i3 This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency www.evaluations-standards.org.uk Email: [email protected]